Novartis is wading deeper into the eye-care business with plans for a $39 billion acquisition of food giant Nestle’s majority stake in Alcon, maker of Opti-Free contact lens solution, and a slew of surgical and pharmaceutical products for the eye.
The move is another push by Novartis to diversify beyond its struggling brand-name drug business. Novartis [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment